Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/1822/83906 |
Resumo: | The phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated pathogenic signalling cascades in a wide variety of cancers. In the last 15 years, there has been an increase in the search for selective inhibitors of the four class I isoforms of PI3K, as they demonstrate better specificity and reduced toxicity in comparison to existing inhibitors. A ligand-based and target-based rational drug design strategy was employed to build a virtual library of 105 new compounds. Through this strategy, the four isoforms were compared regarding their activity pocket availability, amino acid sequences, and prone interactions. Additionally, a known active scaffold was used as a molecular base to design new derivatives. The virtual screening of the resultant library toward the four isoforms points to the obtention of 19 selective inhibitors for the PI3Kα and PI3Kγ targets. Three selective ligands, one for α-isoform and two for γ-isoform, present a ∆ (∆Gbinding) equal or greater than 1.5 Kcal/mol and were identified as the most promising candidates. A principal component analysis was used to establish correlations between the affinity data and some of the physicochemical and structural properties of the ligands. The binding modes and interactions established by the selective ligands in the active centre of the α and γ isoforms of PI3K were also investigated. After modelling studies, a synthetic approach to generate selective ligands was developed and applied in synthesising a set of derivatives that were obtained in good to excellent yield. |
id |
RCAP_20e6b8a8db175cf1840bc68a75f36398 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/83906 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoformsCancerIsoform-specific PI3K inhibitorsDockingAnticancer compoundsTargeted therapyScience & TechnologyThe phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated pathogenic signalling cascades in a wide variety of cancers. In the last 15 years, there has been an increase in the search for selective inhibitors of the four class I isoforms of PI3K, as they demonstrate better specificity and reduced toxicity in comparison to existing inhibitors. A ligand-based and target-based rational drug design strategy was employed to build a virtual library of 105 new compounds. Through this strategy, the four isoforms were compared regarding their activity pocket availability, amino acid sequences, and prone interactions. Additionally, a known active scaffold was used as a molecular base to design new derivatives. The virtual screening of the resultant library toward the four isoforms points to the obtention of 19 selective inhibitors for the PI3Kα and PI3Kγ targets. Three selective ligands, one for α-isoform and two for γ-isoform, present a ∆ (∆Gbinding) equal or greater than 1.5 Kcal/mol and were identified as the most promising candidates. A principal component analysis was used to establish correlations between the affinity data and some of the physicochemical and structural properties of the ligands. The binding modes and interactions established by the selective ligands in the active centre of the α and γ isoforms of PI3K were also investigated. After modelling studies, a synthetic approach to generate selective ligands was developed and applied in synthesising a set of derivatives that were obtained in good to excellent yield.This work was supported by Fundação para a Ciência e a Tecnologia (FCT—Portugal) in the framework of the strategic funding of UIDB/04469/2020 unit and CQUM (UIDB/00686/2020), by LABBELS, Associate Laboratory in Biotechnology, Bioengineering, and Microelectromechanical Systems, LA/P/0029/2020, and by funds from FEDER/FCT through the project PTDC/MEDONC/31354/2017.info:eu-repo/semantics/publishedVersionMultidisciplinary Digital Publishing Institute (MDPI)Universidade do MinhoLobo, VítorRocha, AshlyCastro, Tarsila GabrielCarvalho, M. Alice2023-03-292023-03-29T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/83906engLobo, Vítor; Rocha, Ashly; Castro, T.; Carvalho, Maria Alice, Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms. Polymers, 15(7), 1703, 20232073-436010.3390/polym150717031703http://www.mdpi.com/journal/polymersinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:41:33Zoai:repositorium.sdum.uminho.pt:1822/83906Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:38:33.255671Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
title |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
spellingShingle |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms Lobo, Vítor Cancer Isoform-specific PI3K inhibitors Docking Anticancer compounds Targeted therapy Science & Technology |
title_short |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
title_full |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
title_fullStr |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
title_full_unstemmed |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
title_sort |
Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms |
author |
Lobo, Vítor |
author_facet |
Lobo, Vítor Rocha, Ashly Castro, Tarsila Gabriel Carvalho, M. Alice |
author_role |
author |
author2 |
Rocha, Ashly Castro, Tarsila Gabriel Carvalho, M. Alice |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Lobo, Vítor Rocha, Ashly Castro, Tarsila Gabriel Carvalho, M. Alice |
dc.subject.por.fl_str_mv |
Cancer Isoform-specific PI3K inhibitors Docking Anticancer compounds Targeted therapy Science & Technology |
topic |
Cancer Isoform-specific PI3K inhibitors Docking Anticancer compounds Targeted therapy Science & Technology |
description |
The phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated pathogenic signalling cascades in a wide variety of cancers. In the last 15 years, there has been an increase in the search for selective inhibitors of the four class I isoforms of PI3K, as they demonstrate better specificity and reduced toxicity in comparison to existing inhibitors. A ligand-based and target-based rational drug design strategy was employed to build a virtual library of 105 new compounds. Through this strategy, the four isoforms were compared regarding their activity pocket availability, amino acid sequences, and prone interactions. Additionally, a known active scaffold was used as a molecular base to design new derivatives. The virtual screening of the resultant library toward the four isoforms points to the obtention of 19 selective inhibitors for the PI3Kα and PI3Kγ targets. Three selective ligands, one for α-isoform and two for γ-isoform, present a ∆ (∆Gbinding) equal or greater than 1.5 Kcal/mol and were identified as the most promising candidates. A principal component analysis was used to establish correlations between the affinity data and some of the physicochemical and structural properties of the ligands. The binding modes and interactions established by the selective ligands in the active centre of the α and γ isoforms of PI3K were also investigated. After modelling studies, a synthetic approach to generate selective ligands was developed and applied in synthesising a set of derivatives that were obtained in good to excellent yield. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-03-29 2023-03-29T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1822/83906 |
url |
https://hdl.handle.net/1822/83906 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Lobo, Vítor; Rocha, Ashly; Castro, T.; Carvalho, Maria Alice, Synthesis of novel 2,9-disubstituted-6-morpholino purine derivatives assisted by virtual screening and modelling of class I PI3K isoforms. Polymers, 15(7), 1703, 2023 2073-4360 10.3390/polym15071703 1703 http://www.mdpi.com/journal/polymers |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132922923450368 |